- Device
- VENTANA MET (SP44) RxDx Assay
- Applicant
- Ventana Medical Systems, Inc. (Roche Tissue Diagnostics)
- PMA number
- P240037
- Supplement
- S003
- Product code
- SER
- Generic name
- Immunohistochemistry Assay, Antibody, MET
- Decision date
- 2026-10-23
- Decision code
- APPR
- Date received
- 2026-08-12
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Labeling Change - PAS
- Approval order statement
- Approval to update the labeling for the VENTANA MET (SP44) RxDx Assay to include results of supplemental data provided in the Post-Approval Study (PAS) Report P240037/R004 for utilization of SurePath for preparation of cytology specimens.